Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 8207-8212

  Cooper, L J N ^a   Kalos, M ^a   Lewinsohn, D A ^a   Riddell, S R ^a   Greenberg, P D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOGLYCERATE KINASE; VIRUS VECTOR;

ADOPTIVE TRANSFER; APOPTOSIS; ARTICLE; COMPLEX FORMATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REPRODUCIBILITY; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS LOAD;

CLONING, MOLECULAR; EPITOPES; GENE TRANSFER TECHNIQUES; GENES, T-CELL RECEPTOR; GENETIC VECTORS; HIV-1; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, HIV; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033887418     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.8207-8212.2000     Document Type: Article

References (40)

1. Cloning and expression of the mouse Pgk-1 gene and the nucleotide sequence of its promoter
2. Phenotypic analysis of antigen-specific T lymphocytes
3. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load
4. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome
5. Production of high-titer human immunodeficiency virus type 1 pseudotyped with the vesicular stomatitis virus glycoprotein
6. Gene therapy approaches to HIV-infection: Immunological strategies: Use of T bodies and universal receptors to redirect cytolytic T-cells
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
8. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
9. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
10. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
11. A general method for facilitating heterodimeric pairing between two proteins: Application to expression of α and β T-cell receptor extracellular elements
12. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers
13. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity
14. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing MART-1 melanoma antigen
15. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
16. Ligand recognition by αβ T cell receptors
17. Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes
18. The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation
19. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product
20. New observations on cellular immune responses to HIV and T-cell epitopes
21. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
22. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus infected macaques
23. Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: A phenotypic characterization
24. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
25. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
26. Use of retroviral vectors for gene transfer and expression
27. Cytotoxic T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
28. Quantification of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
29. Peptide 'velcro': Design of a heterodimeric coiled coil
30. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS
31. A retroviral vector that directs simultaneous expression of alpha and beta T cell receptor genes
32. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
33. Principles for adoptive T cell therapy of human viral diseases
34. Restoration of viral immunity in immunocompromised humans by the adoptive transfer of T cell clones
35. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection
36. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors
37. Role of cellular immunity in protection against HIV infection
38. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
39. Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T cell clones from the donor
40. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells